THOXF (Bioporto AS) Interest Expense: $-0.08 Mil (TTM As of Dec. 2025)

What is Bioporto AS Interest Expense?

Bioporto AS THOXF 66 Interest Expense is $-0.08 Mil as of Dec. 2025. GuruFocus rates THOXF with a GF Score™ of 66/100 and a GF Value™ of $0.17. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bioporto AS's interest expense for the three months ended in Dec. 2025 was $ 0.32 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bioporto AS's Operating Income for the three months ended in Dec. 2025 was $ -2.19 Mil. Bioporto AS's Interest Expense for the three months ended in Dec. 2025 was $ 0.32 Mil. Bioporto AS did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bioporto AS (OTCPK:THOXF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bioporto AS's Interest Expense for the three months ended in Dec. 2025 was $0.32 Mil. Its Operating Income for the three months ended in Dec. 2025 was $-2.19 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2025 was $0.64 Mil.

Bioporto AS's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Bioporto AS Interest Expense Historical Data

* Premium members only.

The historical data trend for Bioporto AS's Interest Expense can be seen below:

Bioporto AS Interest Expense Chart

Bioporto AS Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.14

-0.16

-0.08

-0.06

-0.09

Bioporto AS Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Interest Expense	Get a 7-Day Free Trial															0.15	-0.09	-0.24	-0.06	0.32

66GF Score

Bioporto AS THOXF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bioporto AS Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.08 Mil mean?

Bioporto AS (THOXF) has a Interest Expense of $-0.08 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bioporto AS and its competitors.

Is Bioporto AS's Interest Expense too high?

Bioporto AS's current Interest Expense is $-0.08 Mil. Overall, Bioporto AS has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.

How does Bioporto AS's Interest Expense compare to TMO and DHR?

Bioporto AS's Interest Expense of $-0.08 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Diagnostics & Research company?

A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bioporto AS and its competitors. Bioporto AS's current Interest Expense is $-0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bioporto AS stock overvalued right now?

Bioporto AS (THOXF) has a current Interest Expense of $-0.08 Mil. The stock's GF Value™ is $0.17, compared to a current price of $0.15 — trading 12.4% below its estimated fair value. The current Interest Expense is $-0.08 Mil. Bioporto AS's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Bioporto AS (THOXF), the current Interest Expense is $-0.08 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioporto AS (THOXF) Overvalued in 2026?

Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued. The current stock price of $0.15 is trading 12.4% below its estimated GF Value™ of $0.17.

Key valuation signals for THOXF:

Interest Expense: $-0.08 Mil
GF Value™: $0.17 vs. price of $0.15 (12.4% below fair value)
GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the THOXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioporto AS Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH MEDP XPAR:ERF ICLR RVTY CRL XPAR:BIM

Other Exchanges BIOPOR:Denmark

Address Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900

Website https://www.bioporto.com

Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.

66GF Score

Get the complete analysis for THOXF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15

Price

$0.17

GF Value

View THOXF Analysis

See Interest Expense data for all stocks →